The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy of trimodal chemoradiotherapy with gemcitabine and cisplatin as a bladder-preserving strategy for the treatment of muscle invasive bladder cancer: A single-arm prospective study.
 
Hiroaki Matsumoto
No Relationships to Disclose
 
Kazuhiro Nagao
No Relationships to Disclose
 
Sho Ozawa
No Relationships to Disclose
 
Masahiro Samoto
No Relationships to Disclose
 
Junichi Mori
No Relationships to Disclose
 
Ryo Inoue
No Relationships to Disclose
 
Yoshiaki Yamamoto
No Relationships to Disclose
 
Seiji Yano
No Relationships to Disclose
 
Hiroshi Hirata
No Relationships to Disclose
 
Tomoyuki Shimabukuro
No Relationships to Disclose
 
Hideyasu Matsuyama
Honoraria - AstraZeneca; Bayer; Janssen; MSD; Sanofi
Consulting or Advisory Role - Janssen; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst)